![](https://psychedelicstockreview.com/wp-content/uploads/2021/10/KCSA-1024x441.png)
The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in psychedelic treatments for mental health disorders.
The agenda highlights companies representing research, drug development, patient care delivery, integrated technology solutions, and patient support services that are crucial components of the reemerging psychedelic industry.
Presenting companies include a variety of business models including drug developers, investment funds, care delivery treatment clinics, cGMP operators, and vertically integrated business models.
![](https://psychedelicstockreview.com/wp-content/uploads/2021/10/KCSA-TABLE-COVER-2-3-1024x529.png)
October 13th Agenda
9:45 AM ET
KCSA Opening Remarks
10:00 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/small_pharma.png)
Small Pharma Inc.
TSX-V: DMT
Peter Rands, CEO
Dr Carol Routledge, Chief Scientific and Medical Officer
10:30 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/awakn.png)
Awakn Life Sciences Corp.
OTCQB: AWKNF | NEO: AWKN
Anthony Tennyson, CEO
11:00 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/HMNC.png)
HMNC Brain Health
Private Company
Benedikt von Braunmühl, CEO
Maximilian Döbler, Head of Operations
11:30 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/enveric.png)
Enveric Biosciences
NASDAQ: ENVB
Joseph Tucker, CEO
12:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/mind_cure.png)
Mind Cure Health Inc.
OTCQX: MCURF | CSE: MCUR
Kelsey Ramsden, President & CEO
12:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/field_trip.png)
Field Trip Health Ltd.
NASDAQ: FTRP | TSX: FTRP
Joseph del Moral, Co-Founder & CEO
1:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/4229/2/novamind.png)
Novamind Inc.
OTCQB: NVMDF | CSE: NM
Yaron Conforti, CEO, Director, Co-Founder
![](https://psychedelicstockreview.com/wp-content/uploads/2021/10/Guide-Dual-Ad-Copy-2.png)
1:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/betterlife.png)
BetterLife Pharma Inc.
OTCQB: BETRF | CSE: BETR
Ahmad Doroudian, CEO & Director
2:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/mynd.png)
MYND Life Sciences Inc.
Pink: MYNDF | CSE: MYND
Dr. Lyle Oberg, CEO
October 14th Agenda
9:50 AM ET
KCSA Opening Remarks
10:00 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/mindset.jpeg)
Mindset Pharma Inc.
OTCQB: MSSTF | CSE: MSET
James Lanthier, CEO
10:30 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/psybio.jpeg)
PsyBio Therapeutics Corp.
OTCQB: PSYBF | TSX-V: PSYB
Evan Levine, Co-Founder, CEO and Director
11:00 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/psyched.png)
Psyched Wellness Ltd.
OTCQB: PSYCF | CSE: PSYC
Jeff Stevens, CEO
11:30 AM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/bright_minds.png)
Bright Minds Biosciences Inc.
OTCQB: BMBIF | CSE: DRUG
Ian McDonald, President & CEO
Josh Blacher, VP of Corporation Development
12:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/MAPS.png)
Fireside Chat
Amy Emerson, CEO, MAPS Public Benefit Corp
Moderated by Tim Regan, SVP, KCSA Strategic Communications
12:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/JLS_2.jpeg)
![advisor shares](https://www.virtualinvestorconferences.com/system/files-encrypted/nasdaq_kms/inline-images/advisor%20shares.png)
Lunch Panel – Investing in Psychedelics and CNS Treatments
Lindsay Hoover, Partner, JLS Fund
Dan Ahrens, PM of the Psychedelics ETF (NYSEArca: PSIL),
AdvisorShares Investments
Moderated by Tim Regan, SVP, KCSA Strategic Communications
1:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/4229/2/cybin.png)
Cybin Inc.
NYSE American: CYBN | NEO: CYBN
Doug Drysdale, CEO
1:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/myco_logo_-_Sarah_Bai.jpg)
Mydecine Innovations Group
Pink: MYCOF | NEO: MYCO
Joshua Bartch, CEO
2:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/4229/2/neonmind.png)
NeonMind Biosciences Inc.
OTCQB: NMDBF | CSE: NEON
Rob Tessarolo, President & CEO
2:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/Numinus_Wellness_Inc__Logo_-_Sarah_Bai.jpg)
Numinus Wellness Inc.
TSX-V: NUMI
Payton Nyquvest, Founder & CEO
3:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/558/2/Tryp_New_Logo_(1).png)
Tryp Therapeutics Inc.
OTCQB: TRYPF | CSE: TRYP
Luke Hayes, CFO
3:30 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/4229/2/wesana.png)
Wesana Health Holdings Inc.
OTCQB: WSNAF | CSE: WESA
Daniel Carcillo, CEO
4:00 PM ET
![Company Name Logo](https://content.onlinexperiences.com/FileLibrary/4229/2/filament.png)
Filament Health Corp.
Pink: FLHLF | NEO: FH
Ben Lightburn, CEO
![](https://psychedelicstockreview.com/wp-content/uploads/2021/10/Newsletter-1-1024x355.png)